Breaking News Bar

Business News and Information

The Daily Herald Market Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Otonomy Inc (NQ: OTIC)
2.760 USD  -0.010 (-0.36%)
Streaming Delayed Price  /  Updated: 1:26 PM EDT, Oct 17, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 155,643
Open 2.890
Bid (Size) 2.750 (6)
Ask (Size) 2.770 (3)
Prev. Close 2.770
Today's Range 2.690 - 2.890
52wk Range 2.210 - 6.450
Shares Outstanding 30,577,526
Dividend Yield N/A
Performance
YTD
-52.82%
-52.82%
1 Month
+4.15%
+4.15%
3 Month
-26.40%
-26.40%
6 Month
-31.43%
-31.43%
1 Year
-23.33%
-23.33%
Top News
More News
Otonomy Announces OTIVIDEX™ Data Presentation at American Academy of Otolaryngology - Head and Neck Surgery Foundation Annual Meeting
Positive Results from AVERTS-2 Phase 3 Clinical Trial will Support Submission for U.S. Registration and Provide Basis for Ongoing Additional Phase 3 Trial Read More
from GlobeNewswire News Releases
Otonomy to Present at Cantor Fitzgerald Global Healthcare Conference
Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that David A. Weber, Ph.D., president and chief executive... Read More
from GlobeNewswire News Releases
More News
Read More
Oculis Elects Anthony Rosenberg and David A. Weber - Veterans of the Global Pharmaceutical and Eye-care Industries - to its Board of Directors
from PR Newswire
Research Report Identifies Blue Apron, Otonomy, InnerWorkings, Rent-A-Center, NOW, and Flotek Industries with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
from GlobeNewswire News Releases
Otonomy Reports Second Quarter 2018 Financial Results and Provides Corporate Update
from GlobeNewswire News Releases
Otonomy Announces OTIPRIO® Co-Promotion Agreement with Mission Pharmacal for Acute Otitis Externa Indication
from GlobeNewswire News Releases
Otonomy to Report Second Quarter 2018 Financial Results and Provide Corporate Update
from GlobeNewswire News Releases
Otonomy Initiates Phase 3 Clinical Trial of OTIVIDEX™ in Ménière’s Disease
from GlobeNewswire News Releases
Consolidated Research: 2018 Summary Expectations for New York Community, Expedia, DowDuPont, Akamai Technologies, Energy Transfer Equity, and Otonomy — Fundamental Analysis, Key Performance Indication
from GlobeNewswire News Releases
Report: Exploring Fundamental Drivers Behind Valvoline, KKR & Co., Otonomy, Radian Group, Red Rock Resorts, and Quest Diagnostics — New Horizons, Emerging Trends, and Upcoming Developments
from GlobeNewswire News Releases
Otonomy Reports First Quarter 2018 Financial Results and Provides Corporate Update
from GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account